Research Fellow
| Posting date: | 16 May 2025 |
|---|---|
| Salary: | £35,116.00 to £45,413.00 per year |
| Hours: | Full time |
| Closing date: | 15 June 2025 |
| Location: | Warwick, Warwickshire |
| Remote working: | On-site only |
| Company: | University of Warwick |
| Job type: | Temporary |
| Job reference: | 110520-0525 |
Summary
For informal enquiries, please contact Steven P. Brown (Professor) s.p.brown@warwick.ac.uk
We will consider applications for employment on a part-time or other flexible working basis, even where a position is advertised as full-time, unless there are operational or other objective reasons why it is not possible to do so.
The appointee will be one of three Research Fellows appointed on an EPSRC International Centre-to-Centre grant entitled: “Pushing the Limits of High-Field Solid-State NMR Technology: Enhancing Applications to Advanced Materials, the Life Sciences and Pharmaceuticals” that has been awarded to Principle Investigator’s at a consortium of Universities (University of Warwick, University of St Andrews, University of Southampton, University of Liverpool, Lancaster University and University of Birmingham). This 26-month position is focused on applications of state-of-the-art high field solid-state NMR to pharmaceuticals. The lead supervisor is Professor Steven Brown at Warwick, in collaboration with Professor Frédéric Blanc at Liverpool, as well as Professor Józef Lewandowski at Warwick. The research program is centred around the exchange of expertise between the UK High-Field Solid-State NMR National Research Facility (NRF), The UK High-Field Solid-State NMR Facility (warwick.ac.uk), that is hosted at the University of Warwick and several ≥ 1GHz NMR centres around the world. There is also interaction with industry partners: AstraZeneca, Bristol-Myers Squibb, Bruker Biospin, Merck, Quotient Sciences, and Pfizer. The NRF provides access to a 850 MHz wide bore and a 1 GHz narrow bore Bruker Neo spectrometer, as well as a recently installed 1.2 GHz system. The facility has a large variety of MAS probes including a 0.5 mm probe spinning up to 160 kHz, a DOR probe, a 7 mm LASER probe, and 0.7 mm, 1 mm, 1.3 mm, 1.6 mm, 1.9 mm, 2.5 mm, 3.2 mm, 4 mm and 7 mm probes, with a large variety of triple resonance combination, and extended variable temperature capabilities.
The anticipated start date is 1st August 2025 or as soon as possible thereafter, for a duration of 26 months.
You should hold, or be about to attain, a PhD in solid-state NMR as applied to chemistry/ pharmacy/ materials science and/ life sciences. You will be enthusiastic about the capabilities of solid-state NMR to answer questions relating to structure and dynamics at the atomic level with applications to pharmaceuticals.
For further information regarding the skills required for this role please see the personal specification section of the attached job description.
We will consider applications for employment on a part-time or other flexible working basis, even where a position is advertised as full-time, unless there are operational or other objective reasons why it is not possible to do so.
The appointee will be one of three Research Fellows appointed on an EPSRC International Centre-to-Centre grant entitled: “Pushing the Limits of High-Field Solid-State NMR Technology: Enhancing Applications to Advanced Materials, the Life Sciences and Pharmaceuticals” that has been awarded to Principle Investigator’s at a consortium of Universities (University of Warwick, University of St Andrews, University of Southampton, University of Liverpool, Lancaster University and University of Birmingham). This 26-month position is focused on applications of state-of-the-art high field solid-state NMR to pharmaceuticals. The lead supervisor is Professor Steven Brown at Warwick, in collaboration with Professor Frédéric Blanc at Liverpool, as well as Professor Józef Lewandowski at Warwick. The research program is centred around the exchange of expertise between the UK High-Field Solid-State NMR National Research Facility (NRF), The UK High-Field Solid-State NMR Facility (warwick.ac.uk), that is hosted at the University of Warwick and several ≥ 1GHz NMR centres around the world. There is also interaction with industry partners: AstraZeneca, Bristol-Myers Squibb, Bruker Biospin, Merck, Quotient Sciences, and Pfizer. The NRF provides access to a 850 MHz wide bore and a 1 GHz narrow bore Bruker Neo spectrometer, as well as a recently installed 1.2 GHz system. The facility has a large variety of MAS probes including a 0.5 mm probe spinning up to 160 kHz, a DOR probe, a 7 mm LASER probe, and 0.7 mm, 1 mm, 1.3 mm, 1.6 mm, 1.9 mm, 2.5 mm, 3.2 mm, 4 mm and 7 mm probes, with a large variety of triple resonance combination, and extended variable temperature capabilities.
The anticipated start date is 1st August 2025 or as soon as possible thereafter, for a duration of 26 months.
You should hold, or be about to attain, a PhD in solid-state NMR as applied to chemistry/ pharmacy/ materials science and/ life sciences. You will be enthusiastic about the capabilities of solid-state NMR to answer questions relating to structure and dynamics at the atomic level with applications to pharmaceuticals.
For further information regarding the skills required for this role please see the personal specification section of the attached job description.